Caryn E. Lerman
Department of Psychiatry
University of Pennsylvania
Philadelphia
Pennsylvania
USA
Name/email consistency: high
- Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy. Lerman, C., Jepson, C., Wileyto, E.P., Patterson, F., Schnoll, R., Mroziewicz, M., Benowitz, N., Tyndale, R.F. Clin. Pharmacol. Ther. (2010)
- Reinforcing effects of smoking: more than a feeling. Lerman, C., Audrain-McGovern, J. Biol. Psychiatry (2010)
- Translational research in medication development for nicotine dependence. Lerman, C., LeSage, M.G., Perkins, K.A., O'Malley, S.S., Siegel, S.J., Benowitz, N.L., Corrigall, W.A. Nat. Rev. Drug. Discov (2007)
- Genetics and smoking cessation improving outcomes in smokers at risk. Lerman, C.E., Schnoll, R.A., Munafò, M.R. Am. J. Prev. Med (2007)
- Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. Lerman, C., Jepson, C., Wileyto, E.P., Epstein, L.H., Rukstalis, M., Patterson, F., Kaufmann, V., Restine, S., Hawk, L., Niaura, R., Berrettini, W. Neuropsychopharmacology (2006)
- Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Lerman, C., Tyndale, R., Patterson, F., Wileyto, E.P., Shields, P.G., Pinto, A., Benowitz, N. Clin. Pharmacol. Ther. (2006)
- Treating tobacco dependence: state of the science and new directions. Lerman, C., Patterson, F., Berrettini, W. J. Clin. Oncol. (2005)
- Genetic testing for cancer susceptibility: the promise and the pitfalls. Lerman, C., Shields, A.E. Nat. Rev. Cancer (2004)
- The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial. Lerman, C., Wileyto, E.P., Patterson, F., Rukstalis, M., Audrain-McGovern, J., Restine, S., Shields, P.G., Kaufmann, V., Redden, D., Benowitz, N., Berrettini, W.H. Pharmacogenomics J. (2004)
- Changes in food reward following smoking cessation: a pharmacogenetic investigation. Lerman, C., Berrettini, W., Pinto, A., Patterson, F., Crystal-Mansour, S., Wileyto, E.P., Restine, S.L., Leonard, D.G., Shields, P.G., Epstein, L.H. Psychopharmacology (Berl.) (2004)
- Effect of bupropion on depression symptoms in a smoking cessation clinical trial. Lerman, C., Niaura, R., Collins, B.N., Wileyto, P., Audrain-McGovern, J., Pinto, A., Hawk, L., Epstein, L.H. Psychol. Addict. Behav (2004)
- Elucidating the role of genetic factors in smoking behavior and nicotine dependence. Lerman, C., Berrettini, W. Am. J. Med. Genet. B Neuropsychiatr. Genet. (2003)
- Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial. Lerman, C., Shields, P.G., Wileyto, E.P., Audrain, J., Hawk, L.H., Pinto, A., Kucharski, S., Krishnan, S., Niaura, R., Epstein, L.H. Health. Psychol (2003)
- Genetic testing: psychological aspects and implications. Lerman, C., Croyle, R.T., Tercyak, K.P., Hamann, H. J. Consult. Clin. Psychol (2002)
- Mediating mechanisms for the impact of bupropion in smoking cessation treatment. Lerman, C., Roth, D., Kaufmann, V., Audrain, J., Hawk, L., Liu, A., Niaura, R., Epstein, L. Drug. Alcohol. Depend (2002)
- Applying genetic approaches to the treatment of nicotine dependence. Lerman, C., Niaura, R. Oncogene (2002)
- Pharmacogenetic investigation of smoking cessation treatment. Lerman, C., Shields, P.G., Wileyto, E.P., Audrain, J., Pinto, A., Hawk, L., Krishnan, S., Niaura, R., Epstein, L. Pharmacogenetics (2002)
- Attention-Deficit Hyperactivity Disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program. Lerman, C., Audrain, J., Tercyak, K., Hawk, L.W., Bush, A., Crystal-Mansour, S., Rose, C., Niaura, R., Epstein, L.H. Nicotine Tob. Res. (2001)